Genetic mouse models relevant to schizophrenia: Taking stock and looking forward

Neuropharmacology

Volumn 62, Issue 3, 2012, Pages 1164-1167

  Harrison, Paul J ^a   Pritchett, David ^a   Stumpenhorst, Katharina ^a   Betts, Jill F ^a,b   Nissen, Wiebke ^b   Schweimer, Judith ^a,b   Lane, Tracy ^a   Burnet, Philip W J ^a   Lamsa, Karri P ^b   Sharp, Trevor ^b   Bannerman, David M ^b   Tunbridge, Elizabeth M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; GLUTAMATE RECEPTOR 1;

DISEASE ASSOCIATION; DISRUPTED IN SCHIZOPHRENIA 1 GENE; GENE; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MANIPULATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; NEUREGULIN 1 GENE; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84856093355     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.08.009     Document Type: Note

References (45)

1. L.C. Amann, M.J. Gandal, T.B. Halene, R.S. Ehrlichman, S.L. White, H.S. McCarren, and S.J. Siegel Mouse behavioral endophenotypes for schizophrenia Brain Res. Bull. 83 2010 147 161
2. P.A. Arguello, and J.A. Gogos Modeling madness in mice: one piece at a time Neuron 52 2006 179 196 (Pubitemid 44466363)
3. P.A. Arguello, and J.A. Gogos Cognition in mouse models of schizophrenia susceptibility genes Schizophr. Bull. 36 2010 289 300
4. Y. Ayhan, A. Sawa, C.A. Ross, and M.V. Pletnikov Animal models of gene-environment interactions in schizophrenia Behav. Brain Res. 204 2009 274 281
5. C. Barkus, M. Feyder, C. Graybeal, T. Wright, L. Wiedholz, A. Izquierdo, C. Kiselycznyk, W. Schmitt, D.J. Sanderson, N.P. Rawlins, L.M. Saksida, T.J. Bussey, R. Sprengel, D. Bannerman, and A. Holmes Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? Neuropharmacology 62 3 2012 1263 1273
6. J.E. Belforte, V. Zsiros, E.R. Sklar, Z.H. Jiang, G. Yu, Y.Q. Li, E.M. Quinlan, and K. Nakazawa Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes Nat. Neurosci. 13 2010 76 U240
7. G.B. Bissonette, and E.M. Powell Reversal learning and attentional set-shifting in mice Neuropharmacology 62 3 2012 1168 1174
8. N.J. Bradshaw, and D.J. Porteous DISC1-binding proteins in neural development, signalling and schizophrenia Neuropharmacology 62 3 2012 1230 1241
9. T.J. Bussey, A. Holmes, L. Lyon, A. Mar, K.A. McAllister, J. Nithianantharajah, C. Oomen, and L.M. Saksida New translational assays for preclinical modeling of cognition in schizophrenia: the touchscreen testing method for mice and rats Neuropharmacology 62 3 2012 1191 1203
10. C.S. Carter, D.M. Barch, R.W. Buchanan, E. Bullmore, J.H. Krystal, J. Cohen, M. Geyer, M. Green, K.H. Nuechterlein, T. Robbins, S. Silverstein, E.E. Smith, M. Strauss, T. Wykes, and R. Heinssen Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the cognitive neuroscience treatment research to improve cognition in schizophrenia initiative Biol. Psychiatry 64 2008 4 10
11. J.N. Crawley Behavioral phenotyping strategies for mutant mice Neuron 57 2008 809 818 (Pubitemid 351400639)
12. I.H. Deakin, A.J. Law, P.L. Oliver, M.H. Schwab, K.A. Nave, P.J. Harrison, and D.M. Bannerman Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice Neuroreport 20 2009 1523 1528
13. Deakin, I.H.; Nissen, W.; Law, A.J.; Lane, T.; Kanso, R.; Schwab, M.; Nave, K.-A.; Lamsa, K.P.; Paulsen, O.; Bannerman, D.M.; Harrison, P.J.; 2011. Transgenic over-expression of the type I isoform of neuregulin 1 (NRG1) affects working memory and hippocampal oscillations but not long term potentiation. Cereb Cortex (in press).
14. M.J. Gandal, J.C. Edgar, K. Klook, and S.J. Siegel Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia Neuropharmacology 62 3 2012 1504 1518
15. K.A. Garbett, S. Horvath, P.J. Ebert, M.J. Schmidt, K. Lwin, A. Mitchell, P. Levitt, and K. Mirnics Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression Mol. Psychiatry 15 2010 987 995
16. G. Gilmour, S. Dix, L. Fellini, F. Gastambide, N. Plath, T. Steckler, J. Talpos, and M. Tricklebank NMDA receptors, cognition and schizophrenia - testing the validity of the NMDA receptor hypofunction hypothesis Neuropharmacology 62 3 2012 1401 1412
17. R. Hashimoto, R.E. Straub, C.S. Weickert, T.M. Hyde, J.E. Kleinman, and D.R. Weinberger Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia Mol. Psychiatry 9 2004 299 307 (Pubitemid 38496722)
18. S.J. Huffaker, J.S. Chen, K.K. Nicodemus, F. Sambataro, F. Yang, V. Mattay, B.K. Lipska, T.M. Hyde, J. Song, D. Rujescu, I. Giegling, K. Mayilyan, M.J. Proust, A. Soghoyan, G. Caforio, J.H. Callicott, A. Bertolino, A. Meyer-Lindenberg, J. Chang, Y.J. Ji, M.F. Egan, T.E. Goldberg, J.E. Kleinman, B. Lu, and D.R. Weinberger A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia Nat. Med. 15 2009 509 518
19. H. Jaaro-Peled, Y. Ayhan, M.V. Pletnikov, and A. Sawa Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models Schizophr. Bull. 36 2010 301 313
20. M. Johnstone, P.A. Thomson, J. Hall, A.M. McIntosh, S.M. Lawrie, and D.J. Porteous DISC1 in schizophrenia: genetic mouse models and human genomic imaging Schizophr. Bull. 37 2011 14 20
21. M. Karayiorgou, T.J. Simon, and J.A. Gogos 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia Nat. Rev. Neurosci. 11 2010 402 416
22. C. Kellendonk, E.H. Simpson, and E.R. Kandel Modeling cognitive endophenotypes of schizophrenia in mice Trends Neurosci. 32 2009 347 358
23. J.E. Kleinman, A.J. Law, B.K. Lipska, T.M. Hyde, J.K. Ellis, P.J. Harrison, and D.R. Weinberger Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains Biol. Psychiatry 69 2011 140 145
24. V. Labrie, A.H.C. Wong, and J.C. Roder Contributions of the d-serine pathway to schizophrenia Neuropharmacology 62 3 2012 1484 1503
25. A.J. Law, B.K. Lipska, C.S. Weickert, T.M. Hyde, R.E. Straub, R. Hashimoto, P.J. Harrison, J.E. Kleinman, and D.R. Weinberger Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease Proc. Natl. Acad. Sci. USA 103 2006 6747 6752
26. T.V. Lipina, M. Wang, F. Liu, and J.C. Roder Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice Neuropharmacology 62 3 2012 1252 1262
27. B.K. Lipska, and J.A. Gogos Animal models of schizophrenia D.R. Weinberger, P.J. Harrison, Schizophrenia third ed. 2011 Wiley Blackwell Oxford 462 484
28. B.K. Lipska, and D.R. Weinberger To model a psychiatric disorder in animals: schizophrenia as a reality test Neuropsychopharmacology 23 2000 223 239 (Pubitemid 30609657)
29. Lyon, L.; Burnet, P.W.J.; Kew, J.N.C.; Corti, C.; Rawlins, J.N.P.; Lane, T.; de Filippis, B.; Harrison, P.J.; Bannerman, D.M.; 2011. Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition. Neuropsychopharmacology. doi:10.1038/npp.2011.145.
30. W.H. Meck, R.-K. Cheng, C.J. MacDonald, R.R. Gainetdinov, M.G. Caron, and M.O. Cevik Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout mice Neuropharmacology 62 3 2012 1221 1229
31. H. Moore The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy Schizophr. Bull. 36 2010 1066 1072
32. E.J. Nestler, and S.E. Hyman Animal models of neuropsychiatric disorders Nat. Neurosci. 13 2010 1161 1169
33. M. Niwa, A. Kamiya, R. Murai, K. Kubo, A.J. Gruber, K. Tomita, L.L. Lu, S. Tomisato, H. Jaaro-Peled, S. Seshadri, H. Hiyama, B. Huang, K. Kohda, Y. Noda, P. O'Donnell, K. Nakajima, A. Sawa, and T. Nabeshima Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits Neuron 65 2010 480 489
34. G. O'Connell, S.M. Lawrie, A.M. McIntosh, and J. Hall Schizophrenia risk genes: implications for future drug development and discovery Biochem. Pharmacol. 81 2011 1367 1373
35. C.M.P. O'Tuathaigh, and J.L. Waddington Mutant mouse models: phenotypic relationships to domains of psychopathology and pathobiology in schizophrenia Schizophr. Bull. 36 2010 243 245
36. C.M. O'Tuathaigh, G.J. O'Sullivan, A. Kinsella, R.P. Harvey, O. Tighe, D.T. Croke, and J.L. Waddington Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice Neuroreport 17 2006 79 83 (Pubitemid 43005745)
37. F. Papaleo, B.K. Lipska, and D.R. Weinberger Mouse models of genetic effects on cognition: relevance to schizophrenia Neuropharmacology 62 3 2012 1204 1220
38. L.L. Peters, R.F. Robledo, C.J. Bult, G.A. Churchill, B.J. Paigen, and K.L. Svenson The mouse as a model for human biology: a resource guide for complex trait analysis Nat. Rev. Genet. 8 2007 58 69 (Pubitemid 46006050)
39. V.M. Pogorelov, J. Nomura, J. Kim, G. Kannan, Y. Ayhan, C. Yang, Y. Taniguchi, B. Abazyan, H. Valentine, I.N. Krasnova, A. Kamiya, J.L. Cadet, D.F. Wong, and M.V. Pletnikov Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model Neuropharmacology 62 3 2012 1242 1251
40. C.M. Powell, and T. Miyakawa Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol. Psychiatry 59 2006 1198 1207
41. S.B. Powell, X. Zhou, and M.A. Geyer Prepulse inhibition and genetic mouse models of schizophrenia Behav. Brain Res. 204 2009 282 294
42. D.J. Sanderson, and D.M. Bannerman The role of habituation in hippocampus-dependent spatial working memory tasks: evidence from GluA1 AMPA receptor subunit knockout mice Hippocampus 2011 10.1002/hipo.20896 AOL publication 6 September 2010
43. J. van Os, B.P.F. Rutten, and R. Poulton Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions Schizophr. Bull. 34 2008 1066 1082
44. M. Van den Buuse Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects Schizophr. Bull. 36 2010 246270
45. J.W. Young, S.B. Powell, V. Risbrough, H.M. Marston, and M.A. Geyer Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia Pharmacol. Ther. 122 2009 150 202